Piper Sandler Boosts UnitedHealth Group (NYSE:UNH) Price Target to $571.00

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target raised by research analysts at Piper Sandler from $566.00 to $571.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an "overweight" rating on the healthcare conglomerate's stock. Piper Sandler's price target would suggest a potential upside of 19.21% from the stock's previous close.

UNH has been the topic of several other reports. Truist Financial reissued a "buy" rating and set a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating for the company in a report on Monday, April 8th. Erste Group Bank reissued a "hold" rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Morgan Stanley dropped their price target on UnitedHealth Group from $618.00 to $584.00 and set an "overweight" rating on the stock in a research report on Friday, April 5th. Finally, TD Cowen dropped their target price on UnitedHealth Group from $607.00 to $546.00 and set a "buy" rating on the stock in a research report on Wednesday, April 10th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $571.20.

UnitedHealth Group Stock Up 2.2 %

Shares of UnitedHealth Group stock traded up $10.10 on Wednesday, hitting $478.99. 8,753,188 shares of the company's stock traded hands, compared to its average volume of 4,466,714. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The firm's 50-day moving average is $490.31 and its 200 day moving average is $515.63. The stock has a market cap of $441.60 billion, a P/E ratio of 20.09, a PEG ratio of 1.22 and a beta of 0.54. UnitedHealth Group has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company's revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.26 EPS. Equities analysts anticipate that UnitedHealth Group will post 27.69 earnings per share for the current year.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently made changes to their positions in the company. Ascension Capital Advisors Inc. acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $216,000. Bellecapital International Ltd. boosted its stake in shares of UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate's stock valued at $7,277,000 after buying an additional 193 shares during the period. Great Valley Advisor Group Inc. boosted its position in UnitedHealth Group by 5.8% during the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate's stock valued at $17,292,000 after purchasing an additional 1,884 shares during the last quarter. Rise Advisors LLC lifted its holdings in shares of UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate's stock valued at $112,000 after buying an additional 163 shares during the last quarter. Finally, Gradient Investments LLC lifted its stake in UnitedHealth Group by 6.3% in the fourth quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate's stock valued at $44,370,000 after acquiring an additional 5,023 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.